Atlas Trials

A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia

Clinical trial NCT05677438 · COMPLETED

Trial details

NCT number
NCT05677438
Sponsor
Chong Kun Dang Pharmaceutical
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Androgenetic Alopecia
Start date
2022-12-20
Primary completion
2023-12-15
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.